KR100887388B1 - Nutraceutical for protecting liver - Google Patents
Nutraceutical for protecting liver Download PDFInfo
- Publication number
- KR100887388B1 KR100887388B1 KR1020070040753A KR20070040753A KR100887388B1 KR 100887388 B1 KR100887388 B1 KR 100887388B1 KR 1020070040753 A KR1020070040753 A KR 1020070040753A KR 20070040753 A KR20070040753 A KR 20070040753A KR 100887388 B1 KR100887388 B1 KR 100887388B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- dietary supplement
- taurine
- liver
- Prior art date
Links
- 210000004185 liver Anatomy 0.000 title description 6
- 239000002417 nutraceutical Substances 0.000 title 1
- 235000021436 nutraceutical agent Nutrition 0.000 title 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 23
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 17
- 229960003080 taurine Drugs 0.000 claims abstract description 11
- 239000004470 DL Methionine Substances 0.000 claims abstract description 10
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000006109 methionine Nutrition 0.000 claims abstract description 10
- 229930182817 methionine Natural products 0.000 claims abstract description 10
- 229960001231 choline Drugs 0.000 claims abstract description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 7
- 239000001257 hydrogen Substances 0.000 claims abstract description 7
- 229940071182 stannate Drugs 0.000 claims abstract description 7
- 235000020727 milk thistle extract Nutrition 0.000 claims abstract description 6
- 229940096421 milk thistle extract Drugs 0.000 claims abstract description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 18
- 235000012000 cholesterol Nutrition 0.000 abstract description 8
- 239000003963 antioxidant agent Substances 0.000 abstract description 7
- 230000003078 antioxidant effect Effects 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 6
- 210000001525 retina Anatomy 0.000 abstract description 6
- 208000004930 Fatty Liver Diseases 0.000 abstract description 5
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 5
- 241000320380 Silybum Species 0.000 abstract description 5
- 235000010841 Silybum marianum Nutrition 0.000 abstract description 5
- 208000010706 fatty liver disease Diseases 0.000 abstract description 5
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract description 5
- 210000005229 liver cell Anatomy 0.000 abstract description 4
- 210000004165 myocardium Anatomy 0.000 abstract description 4
- 239000007901 soft capsule Substances 0.000 abstract description 4
- 230000006378 damage Effects 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 2
- QWJSAWXRUVVRLH-LREBCSMRSA-M 2-hydroxyethyl(trimethyl)azanium;(2r,3r)-2,3,4-trihydroxy-4-oxobutanoate Chemical compound C[N+](C)(C)CCO.OC(=O)[C@H](O)[C@@H](O)C([O-])=O QWJSAWXRUVVRLH-LREBCSMRSA-M 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000036562 nail growth Effects 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 108091008695 photoreceptors Proteins 0.000 description 1
- 229940013712 pineapple extract Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0646—Theanine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 건강보조식품에 관한 것으로, 타우린 100중량부에 대하여, 주석산수소 콜린 40~60중량부, DL-메티오닌 30~45중량부, 밀크씨슬 추출물 10~15중량부를 포함하는 것을 특징으로 하며, 액상 혼합물을 연질캡슐로 감싸 제공함으로써 보관, 섭취의 편의성을 높일 수 있다.The present invention relates to a dietary supplement, characterized in that it comprises 40 to 60 parts by weight of choline hydrogen stannate, 30 to 45 parts by weight of DL-methionine, 10 to 15 parts by weight of milk thistle extract with respect to 100 parts by weight of taurine By providing a liquid mixture wrapped in soft capsules, the convenience of storage and intake can be enhanced.
본 발명의 건강보조식품은 항산화기능으로 간세포, 망막의 손상을 방지하고 지방간을 예방할 뿐 아니라, 콜레스테롤을 감소시키고 피로를 회복시키며, 심장근육을 보호하고 우울증, 뇌졸증을 예방하는 효과가 있다.The dietary supplement of the present invention has an antioxidant function to prevent damage to liver cells and retina and prevent fatty liver, as well as reduce cholesterol and recover fatigue, protect heart muscle, and prevent depression and stroke.
건강보조식품, 타우린, 주석산수소 콜린, DL-메티오닌, 밀크씨슬. Dietary Supplement, Taurine, Choline Hydrogen Tartrate, DL-Methionine, Milk Thistle.
Description
본 발명은 건강보조식품에 관한 것으로, 구체적으로는 간을 보호하고 콜레스테롤을 감소시키는 기능을 하는 건강보조식품에 관한 것이다.The present invention relates to a dietary supplement, and more particularly, to a dietary supplement that functions to protect the liver and reduce cholesterol.
간 보호 효과를 지닌 건강보조식품과 관련된 기술로서, 대한민국 공개특허 제2005-32417호 간기능 개선, 혈중 알코올 감소 및 항산화에 유효한 조성물에서는 락토바실러스, 비피도박테리움과 오리목 추출물, 꿀풀 추출물, 밀크씨슬 추출물, 생두-미강 발효추출물, 순무 농축액, 토마토 추출물, 브로콜리 추출물, 파인애플 추출물, 초유 분말, 베타인, 비타민 B, 비타민 C, 비타민 E를 유효성분으로 하는 조성물 및 이를 이용한 발효유식품, 음료 및 건강보조식품을 제공하여 간기능 개선, 혈중알코올 감소 및 체내 항산화에 유효한 효과를 얻고자 하였다. 또한, 공개특허 제2005-11557호 간기능 개선 조성물에서는 스피루리나, 밀크씨슬, 울금, 표고균사체 추출물, 포공영 추출물, 타우린, 감초 추출물, 비타민 C를 함유하는 조성물을 제공하여 간보호, 콜레스테롤 감소 및 면역활성 효과를 얻고자 하였다.As a technology related to health supplements having a protective effect on liver, the composition effective for improving liver function, reducing blood alcohol and antioxidants in Lactobacillus, Bifidobacterium and Aldera extract, Lamiaceae extract, Milk seed Fermented extract, green bean-rice bran fermented extract, turnip concentrate, tomato extract, broccoli extract, pineapple extract, colostrum powder, betaine, vitamin B, vitamin C, vitamin E composition and fermented milk food, beverage and health using same The supplements were intended to provide effective effects on improving liver function, reducing blood alcohol and antioxidants in the body. In addition, hepatic function improving composition provides a composition containing spirulina, milk thistle, turmeric, shiitake mycelium extract, pogongyoung extract, taurine, licorice extract, vitamin C to protect liver, reduce cholesterol and immunity To obtain an active effect.
본 발명에서는 타우린, 주석산수소 콜린, DL-메티오닌, 밀크씨슬 추출물을 함유하는 건강보조식품을 제공한다.The present invention provides a dietary supplement containing taurine, choline hydrogen stannate, DL-methionine, milk thistle extract.
본 발명에서는 간을 보호하고 콜레스테롤을 감소시키며, 항산화효과, 우울증과 뇌졸증 예방효과를 지닌 건강보조식품을 제공하고자 한다.In the present invention, to provide a dietary supplement that protects the liver, reduces cholesterol, has an antioxidant effect, prevents depression and stroke.
본 발명은 간 보호 효과를 지닌 건강보조식품에 관한 것으로, 타우린, 주석산수소 콜린, DL-메티오닌, 밀크씨슬 추출물을 함유한다.The present invention relates to a dietary supplement with a hepatoprotective effect, which contains taurine, choline hydrogen stannate, DL-methionine, and milk thistle extract.
타우린(Taurine)은 아미노에틸술폰산(H2NCH2CH2SO3H)으로 아미노산과 같이 양성 전해질의 성질을 지니고 있으며, 아미노산에 비하여 낮은 pH에서도 쉽게 이온화하고, 단백질 합성에 사용되지 않으므로 대부분이 유리상태로 존재한다. 타우린은 담즙산과 결합하여 섭취된 지방의 흡수와 유화를 도와주는 역할 및 체내의 총 콜레스테롤 및 LDL콜레스테롤 농도의 증가를 막아주는 역할을 하고, 망막의 광수용체에 함유되어 자외선 등의 원인에 의한 다가불포화지방산의 과산화를 억제함으로써 망막을 안정화시키는 역할을 하며, 뇌에 함유되어 저산소, 또는 산화 스트레스로 인해 과다하게 신경전달 물질이 방출되는 것을 억제하여 신경조직을 보호하는 역할을 한다. 또한, 심근세포내 칼슘 과잉축적을 방지하여 심장근육을 보호하고, 태아의 유산 및 사산을 방지하고 태아의 두뇌 및 망막 등 주요기관의 정상적인 발달을 도 와주며, 항산화 효과로 세포손상을 방지하는 역할을 한다.Taurine is aminoethylsulfonic acid (H 2 NCH 2 CH 2 SO 3 H), which has the properties of a positive electrolyte like amino acids, and is easily ionized at low pH compared to amino acids and is mostly used for protein synthesis. Exists in a state. Taurine binds with bile acids to help absorb and emulsify the ingested fats and prevents an increase in the total cholesterol and LDL cholesterol levels in the body, and is contained in the photoreceptors of the retina. It acts to stabilize the retina by inhibiting the peroxidation of fatty acids, and protects nerve tissue by inhibiting excessive release of neurotransmitters due to hypoxia or oxidative stress contained in the brain. It also protects heart muscle by preventing excessive accumulation of calcium in cardiomyocytes, prevents miscarriage and stillbirth of fetus, helps normal development of major organs such as brain and retina of fetus, and prevents cell damage with antioxidant effect. Do it.
주석산수소 콜린에 포함되어 있는 콜린(Choline)은 비타민B 복합체의 일종으로 레시틴을 구성하는 성분임과 동시에 신경전달물질인 아세틸콜린을 구성하는 성분으로, 기억력의 향상과 두뇌기능 활성화의 역할을 하고, 콜레스테롤과 지방의 대사에 관여하여 지방간을 방지하며, 우울증과 뇌졸증을 예방하는 역할을 한다.Choline is a component of vitamin B complex and acetylcholine, a neurotransmitter, which improves memory and activates brain function. It is involved in the metabolism of cholesterol and fat to prevent fatty liver and to prevent depression and stroke.
DL-메티오닌은 필수아미노산 중 하나로 황을 함유하고 있으며 지방과 친화성이 있다. DL-메티오닌은 레시틴의 생성을 증가시켜 콜레스테롤 수치를 낮추고, 강력한 항산화제로 자유라디칼의 활성을 억제하며, 히스타민의 혈중농도를 낮추고, 모발이나 손발톱의 발육을 촉진하며, 중금속을 제거하는 역할을 한다. 특히, 우울증의 치료효과와 지방간의 억제효과가 알려져 의약품으로 사용되고 있다.DL-Methionine is an essential amino acid containing sulfur and is compatible with fats. DL-methionine increases the production of lecithin, lowers cholesterol levels, inhibits free radical activity with powerful antioxidants, lowers blood levels of histamine, promotes hair and nail growth, and removes heavy metals. In particular, the therapeutic effect of depression and the inhibitory effect of fatty liver are known and used as a medicine.
밀크씨슬(Milk thistle)은 약리활성성분으로 실리마린(Silymarin)을 함유하여 간질환에 특히 유용하다. 밀크씨슬은 강력한 항산화효과로 간의 손상을 막고 간세포의 생성을 촉진하고, 간경화, 만성간염을 포함한 간질환을 완화하며, 알콜이나 각종 약물섭취로 인한 글루타치온 결핍을 예방하여 간을 보호하고 해독효과를 높이는 역할을 한다.Milk thistle is a pharmacologically active ingredient that contains Silymarin and is particularly useful for liver disease. Milk Thistle is a powerful antioxidant that prevents liver damage, promotes the production of liver cells, alleviates liver diseases including cirrhosis and chronic hepatitis, and protects the liver by preventing glutathione deficiency caused by alcohol or various drugs. Height plays a role.
본 발명의 건강보조식품은 타우린 100중량부에 대하여, 주석산수소 콜린 40~60중량부, DL-메티오닌 30~45중량부, 밀크씨슬 추출물 10~15중량부를 포함하는 것을 특징으로 하며, 액상 혼합물을 연질캡슐로 감싸 제공함으로써 보관, 섭취의 편의성을 높일 수 있다.The dietary supplement of the present invention is characterized in that it comprises 40 to 60 parts by weight of choline hydrogen stannate, 30 to 45 parts by weight of DL-methionine, and 10 to 15 parts by weight of milk thistle extract, based on 100 parts by weight of taurine, and a liquid mixture. By encapsulating it in soft capsules, you can increase the convenience of storage and intake.
본 발명에 따른 건강보조식품의 성분비는 상기 배합비율에 국한된 것은 아니나, 특정 성분이 다량, 또는 소량 혼합될 경우 상대적으로 효과가 떨어질 수 있으므로 상기 비율을 벗어나지 않는 것이 바람직하다.The ingredient ratio of the dietary supplement according to the present invention is not limited to the above blending ratio, but it is preferable not to deviate from the ratio since a particular component may be relatively ineffective when mixed with a large amount or a small amount.
[실시예]EXAMPLE
타우린 100g, 주석산수소 콜린 50g, DL-메티오닌 37g, 밀크씨슬 추출물 13g을 고르게 혼합한 후, 1g씩 연질캡슐에 담아 본 발명의 건강보조식품을 제조하였다.Taurine 100g, choline hydrogen stannate 50g, DL- methionine 37g, milk thistle 13g evenly mixed, and then put in a soft capsule 1g each to prepare a health supplement of the present invention.
상기 실시예에 따른 건강보조식품은 연질캡슐에 감싸져 있으므로 보관 및 섭취가 용이하며, 이를 꾸준히 복용함으로써 콜레스테롤을 감소시키고 지방간을 방지하며, 항산화기능으로 망막, 간세포 등의 손상을 방지할 뿐 아니라, 심장근육을 보호하는 효과를 얻을 수 있다.Since the health supplement according to the embodiment is wrapped in a soft capsule, it is easy to store and consume, and by taking it steadily, it reduces cholesterol, prevents fatty liver, and prevents damage to retinas, liver cells, etc. by an antioxidant function. It can help protect the heart muscle.
본 발명에 따른 건강보조식품은 유효성분을 기준으로 성인의 경우 1일 1~3g의 섭취로 원하는 효과를 얻을 수 있다.Health supplements according to the present invention can obtain the desired effect by ingesting 1 ~ 3g per day for adults based on the active ingredient.
본 발명의 건강보조식품은 항산화기능으로 간세포, 망막의 손상을 방지하고 지방간을 예방할 뿐 아니라, 콜레스테롤을 감소시키고 피로를 회복시키며, 심장근육을 보호하고 우울증, 뇌졸증을 예방하는 효과가 있다.The dietary supplement of the present invention has an antioxidant function to prevent damage to liver cells and retina and prevent fatty liver, as well as reduce cholesterol and recover fatigue, protect heart muscle, and prevent depression and stroke.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020070040753A KR100887388B1 (en) | 2007-04-26 | 2007-04-26 | Nutraceutical for protecting liver |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020070040753A KR100887388B1 (en) | 2007-04-26 | 2007-04-26 | Nutraceutical for protecting liver |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20080095995A KR20080095995A (en) | 2008-10-30 |
| KR100887388B1 true KR100887388B1 (en) | 2009-03-05 |
Family
ID=40155434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020070040753A KR100887388B1 (en) | 2007-04-26 | 2007-04-26 | Nutraceutical for protecting liver |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR100887388B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190098429A (en) * | 2018-02-14 | 2019-08-22 | 경기도 양평군(양평군 농업기술센터장) | Method of Manufacturing Tablet Products using Milk Thistle and White Spotted Flowers Larvae |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010113086A (en) * | 2000-06-16 | 2001-12-28 | 김을상 | A soy milk and soy formula added taurine |
| JP2004000823A (en) * | 2002-05-24 | 2004-01-08 | Tohoku Techno Arch Co Ltd | High-speed powder reactor |
| KR20060056202A (en) * | 2004-11-20 | 2006-05-24 | 주식회사 알엔에이 | Composition having preventive and therapeutic effects of liver damage |
-
2007
- 2007-04-26 KR KR1020070040753A patent/KR100887388B1/en active IP Right Grant
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010113086A (en) * | 2000-06-16 | 2001-12-28 | 김을상 | A soy milk and soy formula added taurine |
| JP2004000823A (en) * | 2002-05-24 | 2004-01-08 | Tohoku Techno Arch Co Ltd | High-speed powder reactor |
| KR20060056202A (en) * | 2004-11-20 | 2006-05-24 | 주식회사 알엔에이 | Composition having preventive and therapeutic effects of liver damage |
Non-Patent Citations (1)
| Title |
|---|
| 일간보사 신제품 소개 기사입력일시( 2004.08.23)] |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190098429A (en) * | 2018-02-14 | 2019-08-22 | 경기도 양평군(양평군 농업기술센터장) | Method of Manufacturing Tablet Products using Milk Thistle and White Spotted Flowers Larvae |
| KR102037205B1 (en) | 2018-02-14 | 2019-10-28 | 경기도 양평군(양평군 농업기술센터장) | Method of Manufacturing Tablet Products using Milk Thistle and White Spotted Flowers Larvae |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080095995A (en) | 2008-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100680121B1 (en) | Formulation containing lyso-phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals | |
| US20070292501A1 (en) | Chewable soft gelatin capsules | |
| US6638542B2 (en) | Reducing appetite in mammals by administering procyanidin and hydroxycitric acid | |
| US20230132388A9 (en) | Intact Pea Protein-Based Nutrient Composition | |
| TW200913988A (en) | Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient | |
| US11738037B2 (en) | Agent for preventing or improving decline in brain function | |
| JP2021503878A (en) | Compositions and Methods Using Oleuropein or Curcumin for Muscle Quality and / or Muscle Mass | |
| CN105935364B (en) | Composition comprising ginsenoside F2 for preventing or treating non-alcoholic liver disease | |
| US20190008814A1 (en) | Composition for preventing or improving peripheral neuropathy | |
| RU2012145109A (en) | METHOD FOR INCREASING TASTE ATTRACTIVENESS OF EDIBLE COMPOSITIONS | |
| EP3461479B1 (en) | Nutraceutical and pharmaceutical compositions, and uses thereof for preserving cognitive functions | |
| US20080279837A1 (en) | Composition for maintaining androgen and androgen-like uptake potential by cells | |
| KR101886350B1 (en) | Composition containing triterpenoid saponin extracted from the root of Camellia sinensis | |
| KR100887388B1 (en) | Nutraceutical for protecting liver | |
| CN109198347A (en) | A kind of soybean peptide solid beverage and its application | |
| CN107836533A (en) | It is a kind of can external application beauty care edible purple perilla seed essential oil | |
| US20080260881A1 (en) | Blue-green algae composition | |
| US20080279967A1 (en) | Composition and method for increasing the metabolism of free fatty acids and facilitating a favorable blood lipid | |
| KR20160068238A (en) | Composition for preventing or improving metabolic syndrome containing panasenoside | |
| CN108095067A (en) | A kind of preparation method alleviated visual fatigue and enhance memory capsule | |
| CN101589831A (en) | A kind of multi-nutrient protein drink | |
| US20080279968A1 (en) | Composition and method for inducing lipolysis and increasing the metabolism of free fatty acids | |
| CN204078492U (en) | The packaging structure of filling agate card microgranular texture | |
| CN112450436A (en) | Composition with function of improving cardiovascular function and application | |
| KR20150033910A (en) | The spore of Ganoderma lucidum which has the weight loss effect and the dietary components using this spore of Garnoderma lucidum for weight loss |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20121226 Year of fee payment: 5 |
|
| FPAY | Annual fee payment |
Payment date: 20140214 Year of fee payment: 6 |
|
| FPAY | Annual fee payment |
Payment date: 20150224 Year of fee payment: 7 |
|
| FPAY | Annual fee payment |
Payment date: 20160225 Year of fee payment: 8 |
|
| FPAY | Annual fee payment |
Payment date: 20180226 Year of fee payment: 10 |
|
| FPAY | Annual fee payment |
Payment date: 20190227 Year of fee payment: 11 |
|
| FPAY | Annual fee payment |
Payment date: 20200226 Year of fee payment: 12 |